World

Merck Completes Acquisition of the Chemical Business of Mecaro

Acquisition is expected to complement a key segment of Merck’s Semiconductor Solutions portfolio With the addition of around 100 new employees as ...

 January 03, 2023 | News

Thermo Fisher Scientific Completes Acquisition of The Binding Site Group

Expands Specialty Diagnostics Segment with Industry Leader in Oncology Testing for Detection and Monitoring of Multiple Myeloma  Complements Existing...

 January 03, 2023 | News

Merck Announces Collaboration With Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates

Collaboration complements Merck’s internal expertise and in-house ADC approach Companies focused on discovering novel STING-agonist ADCs for up to...

 December 23, 2022 | News

CorroHealth and Versalus Health Join Forces to Bring More Solutions to Hospitals

Together, Versalus Health and CorroHealth enable transformative healthcare analytics for the full revenue cycle Versalus Heath's cli...

 December 14, 2022 | News

Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates

Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced an exploratory research collaboration to create antibody-drug con...

 December 14, 2022 | News

Lilly Announces 15% Dividend Increase, First-Quarter 2023 Dividend

The dividend is payable on March 10, 2023 to shareholders of record at the close of business on Feb. 15, 2023.   Lilly unites caring with ...

 December 13, 2022 | News

Exact Sciences to Advance Radiation Therapy Benefit in Breast Cancer Patients

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today shared initial clinical validation data for it...

 December 12, 2022 | News

Research Highlights Cutting-Edge New Treatments for Blood Disorders

New research being presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition focuses on a variety of approaches for several ...

 December 12, 2022 | News

10x Genomics Commercially Launches Xenium Platform for In Situ Analysis

 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the first co...

 December 09, 2022 | News

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

Bivalent vaccine authorized as third 3-µg dose in the three-dose primary series Consistent COVID-19 hospitalization rates in this age group couple...

 December 08, 2022 | News

Sartorius agrees with BICO on strategic cooperation as well as a 10 percent capital investment

BICO Group is a pioneer and leading provider of instruments and consumables for bioprinting, bioscience and bioautomation applications in the life scienc...

 December 08, 2022 | News

FDA grants ODD for new NK treatment

The US FDA has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis (NK), a rare degenerative eye diseas...

 December 08, 2022 | News

Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition

Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows Merck t...

 December 07, 2022 | News

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine

The complete manufacturing of BVX-0918 from a cancer patient's ovarian tumor now validates the production protocols that had been in development over the p...

 December 02, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close